Press Releases

• Trial planning and execution to proceed as planned

WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has provided comments on the protocol of a planned clinical trial that will study the use of tafenoquine in treating babesiosis. Babesiosis, a... (continue reading...)

Mark Stevenson, with more than 30 years of experience in the life sciences sector, formerly Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific joins Ultima Genomics’ Board of Directors

FREMONT, Calif.--(BUSINESS WIRE)-- Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that Mark Stevenson will join its Board of Directors. Mark brings more than 30 years of experience and... (continue reading...)

Council will help build data literacy, training resources to improve organizations’ performance

Downers Grove, IL, May 02, 2024 (GLOBE NEWSWIRE) -- CompTIA, the nonprofit association for the information technology (IT) industry, has expanded its role in fostering a data-driven culture with the formation of a new CompTIA Community Data Advisory Council.

The council, comprised of six industry experts from multiple organizations, will help build data literacy and... (continue reading...)

Embarc Expands Presence in Central Valley With Launch of Madera's First Retail Location and the Company's Second in Fresno, Totalling 15 California Stores

SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Respected California cannabis retail operator Embarc has announced the opening of Madera's first cannabis dispensary and the company's second retail location in Fresno. This milestone represents a significant advancement in Embarc's effort to continue providing safe,... (continue reading...)

Repurchased $80.4 million of Shares in the Quarter

Completed Strategic Wards Well Acquisition at Centurion

ST. LOUIS, May 2, 2024 /PRNewswire/ -- Peabody (NYSE: BTU) today reported net income attributable to common stockholders of $39.6 million, or $0.29 per diluted share, for the first quarter of 2024, compared to $268.5 million, or $1.68 per diluted share in the prior year quarter.  Peabody had Adjusted EBITDA1 of $160.5 million in the first quarter of 2024... (continue reading...)